Regulus Therapeutics (NASDAQ: RGLS) announced today that it has earned a milestone payment from Biogen Idec (NASDAQ: BIIB) related to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE